Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome
Main Article Content
Keywords
Haematological patients, Medical Complications, Emergency Room, Co-morbidity
Downloads
Download data is not yet available.
Abstract 288
PDF Downloads 706
HTML Downloads 23
References
1. Kim K, Phelps MA. Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab. Clin Pharmacokinet. 2023 Jun;62(6):789-806. doi: 10.1007/s40262-023-01240-8. Epub 2023 May 2. PMID: 37129750; PMCID: PMC10760401.
2. Paul B, Hamadeh I, Atrash S, Bhutani M, Voorhees P, Usmani SZ. Daratumumab subcutaneous formulation for the treatment of multiple myeloma. Expert Opin Biol Ther. 2020 Nov;20(11):1253-1259. doi: 10.1080/14712598.2020.1806231. Epub 2020 Aug 16. PMID: 32750265.
3. De Angelis G., Fiorini A., Trapè G., Panichi V., Chavez M.G., Emanueli Cippitelli E., Innocenti V., Perazzini R., Talucci R., Topini G., Di Veroli A., Mercanti C., Natalino F., Tarnani M., Morucci M., Mastini C., Silvestri A., Andriani A., Montanaro M., Ciambella S., Latagliata R.: Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report, Blood (2023) 142 (Supplement 1): 7242.
4. Sanguinetti JM, Martínez D, Dimase F, Streich G, Castro P, Vega V, Batagelj E. Patient Safety and Satisfaction in Home Chemotherapy. Home Healthc Now. 2021 May-Jun 01;39(3):139-144. doi: 10.1097/NHH.0000000000000958. PMID: 33955927.
5. Lüthi F, Fucina N, Divorne N, Santos-Eggimann B, Currat-Zweifel C, Rollier P, Wasserfallen JB, Ketterer N, Leyvraz S. Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies. Support Care Cancer. 2012 Mar;20(3):575-81. doi: 10.1007/s00520-011-1125-9. Epub 2011 Mar 8. PMID: 21384139.
6. Joo EH, Rha SY, Ahn JB, Kang HY. Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer. Support Care Cancer. 2011 Jul;19(7):971-8. doi: 10.1007/s00520-010-0917-7. Epub 2010 May 23. PMID: 20496154.
2. Paul B, Hamadeh I, Atrash S, Bhutani M, Voorhees P, Usmani SZ. Daratumumab subcutaneous formulation for the treatment of multiple myeloma. Expert Opin Biol Ther. 2020 Nov;20(11):1253-1259. doi: 10.1080/14712598.2020.1806231. Epub 2020 Aug 16. PMID: 32750265.
3. De Angelis G., Fiorini A., Trapè G., Panichi V., Chavez M.G., Emanueli Cippitelli E., Innocenti V., Perazzini R., Talucci R., Topini G., Di Veroli A., Mercanti C., Natalino F., Tarnani M., Morucci M., Mastini C., Silvestri A., Andriani A., Montanaro M., Ciambella S., Latagliata R.: Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report, Blood (2023) 142 (Supplement 1): 7242.
4. Sanguinetti JM, Martínez D, Dimase F, Streich G, Castro P, Vega V, Batagelj E. Patient Safety and Satisfaction in Home Chemotherapy. Home Healthc Now. 2021 May-Jun 01;39(3):139-144. doi: 10.1097/NHH.0000000000000958. PMID: 33955927.
5. Lüthi F, Fucina N, Divorne N, Santos-Eggimann B, Currat-Zweifel C, Rollier P, Wasserfallen JB, Ketterer N, Leyvraz S. Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies. Support Care Cancer. 2012 Mar;20(3):575-81. doi: 10.1007/s00520-011-1125-9. Epub 2011 Mar 8. PMID: 21384139.
6. Joo EH, Rha SY, Ahn JB, Kang HY. Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer. Support Care Cancer. 2011 Jul;19(7):971-8. doi: 10.1007/s00520-010-0917-7. Epub 2010 May 23. PMID: 20496154.